Published in Drug Week, October 17th, 2003
These findings, from a PROTEKT US (Prospective Resistant Organism Tracking and Epidemiology of the Ketolide Telithromycin - United States) sub-study, were presented at the 43rd annual Interscience Conference on Antimicrobial Agents and Chemotherapy.
A total of 10,012 S. pneumoniae isolates were collected from patients with community-acquired respiratory tract infections in 242 centers across the United States. The study found that 21.2% of the isolates...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.